Imidafenacin
![]() | |
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code | none |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number |
170105-16-5 ![]() |
PubChem (CID) | 6433090 |
ChemSpider |
4938278 ![]() |
UNII |
XJR8Y07LJO ![]() |
ChEMBL |
CHEMBL53366 ![]() |
ECHA InfoCard | 100.216.585 |
Chemical and physical data | |
Formula | C20H21N3O |
Molar mass | 319.40 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
![]() ![]() |
Imidafenacin (INN) is a urinary antispasmodic of the anticholinergic class. Its molecular weight is 319.40 g/mol
References
- Kobayashi F, Yageta Y, Segawa M, Matsuzawa S (2007). "Effects of imidafenacin (KRP-197/ONO-8025), a new anti-cholinergic agent, on muscarinic acetylcholine receptors. High affinities for M3 and M1 receptor subtypes and selectivity for urinary bladder over salivary gland". Arzneimittelforschung. 57 (2): 92–100. doi:10.1055/s-0031-1296589. PMID 17396619.
- Miyachi H, Kiyota H, Uchiki H, Segawa M (June 1999). "Synthesis and antimuscarinic activity of a series of 4-(1-Imidazolyl)-2,2-diphenylbutyramides: discovery of potent and subtype-selective antimuscarinic agents". Bioorg. Med. Chem. 7 (6): 1151–61. doi:10.1016/S0968-0896(99)00003-6. PMID 10428387.
This article is issued from Wikipedia - version of the 11/25/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.